1) Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011 ; 183 : 788-824.
2) Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
3) Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005 ; 171 : 1040-7.
4) Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010 ; 35 : 821-9.
5) King TE Jr, Brown KK, Raghu G, et al. BUILD-3 : a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011 ; 184 : 92-9.
6) Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY) : two randomised trials. Lancet 2011 ; 377 : 1760-9.
7) Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis : a Fleischner Society White Paper. Lancet Respir Med 2017 : doi : 10.1016/s2213-2600 (17) 30433-2 [Ebub ahead of print]
8) Travis WD, Hunninghake G, King TE Jr, et al. Idiopathic nonspecific interstitial pneumonia : report of an American Thoracic Society project. Am J Respir Crit Care Med 2008 ; 177 : 1338-47.
9) Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement : interstitial pneumonia with autoimmune features. Eur Respir J 2015 ; 46 : 976-87.
10) 武村民子. 慢性線維化性間質性肺炎と蜂巣肺の病理. 酒井文和, 上甲 剛, 野間恵之, 編. 特発性肺線維症の画像診断. 東京 : メディカルサイエンスインターナショナル, 2015 : 25-56.
11) Sumikawa H, Johkoh T, Colby TV, et al. Computed tomography findings in pathological usual interstitial pneumonia : relationship to survival. Am J Respir Crit Care Med 2008 ; 177 : 433-9.
12) Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society : glossary of terms for thoracic imaging. Radiology 2008 ; 246 : 697-722.
13) Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003 ; 124 : 1215-23.
14) Johkoh T, Muller NL, Cartier Y, et al. Idiopathic interstitial pneumonias : diagnostic accuracy of thinsection CT in 129 patients. Radiology 1999 ; 211 : 555-60.
15) Akira M, Inoue Y, Kitaichi M, et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema : thin-section CT findings. Radiology 2009 ; 251 : 271-9.
16) Ando Y, Okada F, Matsumoto S, et al. Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) -related disease. CT findings in 51 patients. J Comput Assist Tomogr 2004 ; 28 : 710-6.
17) Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002 ; 19 : 275-83.
18) Iwasawa T, Takemura T, Okudera K, et al. The importance of subpleural fibrosis in the prognosis of patients with idiopathic interstitial pneumonias. Eur J Radiol 2017 ; 90 : 106-13
19) Iwasawa T, Iwao Y, Takemura T, et al. Extraction of the subpleural lung region from computed tomography images to detect interstitial lung disease. Jpn J Radiol 2017 ; doi : 10.1007/s11604-017-0683-2. [Epub ahead of print]
20) Kawabata Y, Hoshi E, Murai K, et al. Smokingrelated changes in the background lung of specimens resected for lung cancer : a semiquantitative study with correlation to postoperative course. Histopathology 2008 ; 53 : 707-14.
21) Katzenstein AL. Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Mod Pathol 2012 ; 25 : S68-78.
22) Watanabe Y, Kawabata Y, Kanauchi T, et al. Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis. Eur J Radiol 2015 ; 84 : 986-92.
23) Omori T, Tajiri M, Baba T, et al. Pulmonary resection for lung cancer in patients with idiopathic interstitial pneumonia. Ann Thorac Surg 2015 ; 100 : 954-60.
24) Sakai S, Ono M, Nishio T, et al. Lung cancer associated with diffuse pulmonary fibrosis : CT-pathologic correlation. J Thorac Imaging 2003 ; 18 : 67-71.
25) Akira M, Kozuka T, Yamamoto S, et al. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008 ; 178 : 372-8.
26) Sprunger DB, Olson AL, Huie TJ, et al. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease. Eur Respir J 2012 ; 39 : 125-32.
27) Iwasawa T, Kato S, Ogura T, et al. Low-normal lung volume correlates with pulmonary hypertension in fibrotic idiopathic interstitial pneumonia : computeraided 3D quantitative analysis of chest CT. AJR Am J Roentgenol 2014 ; 203 : W166-73.
28) Kimura M, Taniguchi H, Kondoh Y, et al. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis. Respiration 2013 ; 85 : 456-63.
29) Kato S, Sekine A, Kusakawa Y, et al. Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease. J Cardiovasc Magn Reson 2015 ; 17 : 10.